Anti-aging fanatic Bryan Johnson bragged his plasma is so squeaky clean that a medical staffer “couldn’t bring himself to throw it away” as the tech mogul revealed a new procedure he is ...

Washington — House Speaker Mike Johnson diverted Sunday on questions about possible violence and security concerns ahead of the certification of the presidential election results early next year ...

We recently compiled a list titled 7 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. In this article, we will look at where Johnson & Johnson (NYSE:JNJ) ranks among the best cheap ...

The author and editors take ultimate responsibility for the content. Johnson & Johnson (JNJ-1.55%) is an iconic global healthcare company. It was originally formed in 1866 when three brothers ...

AnhPhu Nguyen and Caine Ardayfio, a human augmentation and physics researcher at Harvard, respectively, have published a paper that details how the project to build real x-ray specs has led them ...

Johnson, a contributing columnist for The Washington Post, a scholar on race and democracy, and a retired naval officer. His book, "If We Are Brave", was published in October. His research and ...

Christopher K. Johnson is a senior fellow at CSIS. An accomplished Asian affairs specialist, Mr. Johnson spent nearly two decades serving in the U.S. government’s intelligence and foreign affairs ...

Johnson & Johnson has proposed to pay almost $9bn to resolve tens of thousands of lawsuits it faces in North America that claim its baby powder and other talc-based products cause cancer. The ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

Kirk Johnson is the Sant Director of the Smithsonian’s National Museum of Natural History where he oversees the world’s largest natural history collection. The museum hosts more than 6 million ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...